Krishna Institute of Medical Sciences Faces Financial Challenges Amid Strong Revenue Generation

Krishna Institute of Medical Sciences has recently undergone a financial trend adjustment, reflecting challenges in its performance metrics for the quarter ending September 2025. The company's financial score has seen a decline, indicating a need for closer scrutiny of its operational efficiency and market positioning. On a positive note, the company reported its highest operating cash flow at Rs 293.60 crore and net sales reaching Rs 960.70 crore, showcasing strong revenue generation capabilities. However, the company faces significant hurdles, including a notable decline in profit after tax, which fell to Rs 66.90 crore, representing a 27.3% drop compared to the previous four-quarter average. Additionally, the debt-equity ratio has risen to 3.46 times, raising concerns about financial leverage, while the debtors turnover ratio stands at a low 0.70 times, indicating potential issues with receivables management. In terms of performance relative to the broader market, Krishna Institute of Medical Sciences has shown resilience over the year, with a stock return of 23.05% compared to a 5.22% return from the Sensex. This trend highlights the company's ability to outperform the market despite current financial challenges.